Handok Teva announces co-promotion agreement of ‘Azilect’ with Lundbeck Korea
Handok Teva(CEO Sun-dong Park) signed a co-promotion agreement of ‘Azilect,’ a Parkinson’s disease treatment, with Lundbeck Korea at the Lundbeck Korea headquarters in Seoul on the 30th of December.
Under the term of the agreement, the two companies are planning to have 50:50 sales and marketing...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
